| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/11/2009 | WO2007109871A3 Acridine derivatives with antitumoral activity |
| 06/11/2009 | US20090149656 Optical determination of glucose utilizing boronic acid adducts |
| 06/11/2009 | US20090149652 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines |
| 06/11/2009 | US20090149651 Processes and intermediates for producing aminobenzimidazole ureas |
| 06/11/2009 | US20090149528 Cinnamic acid amides |
| 06/11/2009 | US20090149509 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium; 2 (S)-hydroxy-3 (R)-[2 (S)-oxazol-2-yl-pyrrolidine-1-carbonyl)-heptanoic acid hydroxamide |
| 06/11/2009 | US20090149505 Metabotropic Glutamate Receptor-Potentiating Isoindolones |
| 06/11/2009 | US20090149504 Novel 5-Substituted Indole Derivatives As Dipeptidyl Peptidase IV (DPP-IV) Inhibitors |
| 06/11/2009 | US20090149500 solid forms of lenalidomide, treating cancer, inflammatory disease, myelodysplastic syndrome, undesired angiogenesis |
| 06/11/2009 | US20090149499 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione) |
| 06/11/2009 | US20090149493 Inhibitors of the interaction between mdm2 and p53 |
| 06/11/2009 | US20090149476 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
| 06/11/2009 | US20090149474 tert-butyl 4-[(4-chlorobenzoyl)amino]-2-(dimethylamino)-1-phenyl-1H-imidazole-5-carboxylate, used for the treatment of gastrointestinal disorders such as gastroesophageal reflux, irritable bowel syndrome, dyspepsia, diarrhea and for the inhibition of transient lower esophageal sphincter relaxations |
| 06/11/2009 | US20090149472 Salts of substitutted pyrazoline compounds, their preparation and use and medicaments |
| 06/11/2009 | US20090149469 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 06/11/2009 | US20090149468 Substituted heterocyclic compounds and methods of use |
| 06/11/2009 | US20090149467 Tyrosine Kinase Inhibitors |
| 06/11/2009 | US20090149463 Therapeutic agents |
| 06/11/2009 | US20090149460 New Compounds |
| 06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149444 Benzylamine analogues |
| 06/11/2009 | US20090149440 1-(6-Amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-isopropylaminoazetidin-1-yl)-8-methyl-4-oxo-1,4-dihydroquinolin-3-carboxylic acid; antibacterial agent; low toxicity, improved bioavailability, and low binding rate to serum proteins |
| 06/11/2009 | US20090149439 Pyridylmethysulfone derivative |
| 06/11/2009 | US20090149415 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex |
| 06/11/2009 | US20090148382 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 06/11/2009 | US20090145757 Redox Polymers |
| 06/11/2009 | US20090144915 incorporation or grafting of hindered 4-aminopiperidines into a polyolefin, a styrene copolymer or an elastomer; stabilizers for protecting against oxidative, thermal, dynamic, light-induced or ozone-induced degradation; storage stability |
| 06/11/2009 | CA2707989A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
| 06/11/2009 | CA2707822A1 New compounds iii |
| 06/11/2009 | CA2707722A1 Gamma secretase modulators |
| 06/11/2009 | CA2707671A1 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | CA2707669A1 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | CA2707667A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 06/11/2009 | CA2707653A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | CA2707651A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 06/11/2009 | CA2707565A1 Renin inhibitors |
| 06/11/2009 | CA2706420A1 Compounds for therapy and diagnosis |
| 06/11/2009 | CA2705489A1 Pyridylmethyl-sulfonamide compounds |
| 06/10/2009 | EP2067776A1 Piperidine compounds and pharmaceutical compositions containing them |
| 06/10/2009 | EP2066659A1 Substituted sulfonamide derivatives |
| 06/10/2009 | EP2066658A1 Pyridine- and quinoline-pyrimidine-derivatives |
| 06/10/2009 | EP2066657A1 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands |
| 06/10/2009 | EP2066656A2 5-substituted quinazolinone derivatives as antitumor agents |
| 06/10/2009 | EP2066655A2 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 06/10/2009 | EP2066654A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 06/10/2009 | EP2066653A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 06/10/2009 | EP2066645A2 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| 06/10/2009 | EP2066637A1 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
| 06/10/2009 | EP2066636A1 5-phenyl-nicotinamide derivatives |
| 06/10/2009 | EP2066630A1 Piperidine derivatives |
| 06/10/2009 | EP2066318A2 Oxindole derivatives as anticancer agents |
| 06/10/2009 | EP1805142A4 Novel pyridine compounds, process for their preparation and compositions containing them |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | EP0976737B1 Pyrazole derivatives, process for preparing the same, intermediates, and pest control agent containing the same as active ingredient |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | CN101454311A Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 06/10/2009 | CN101454310A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/10/2009 | CN101454309A Synthesis and uses of pyroglutamic acid derivatives |
| 06/10/2009 | CN101454308A Process for preparing heterocyclic derivatives |
| 06/10/2009 | CN101450939A Novel benzimidazoles compounds |
| 06/10/2009 | CN101450938A 7-(4-oximido-3-amido-3-alkyl-1-piperidine)quinoline carboxylic acid derivates and preparation method thereof |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497334C Indole derivatives useful as histamine h3 antagonists |
| 06/10/2009 | CN100497333C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders |
| 06/10/2009 | CN100497332C Compound for preparing nifeviroc and its preparing process |
| 06/10/2009 | CN100497331C 7-(4-oxime-3-amino-1-piperidine) quinoline carboxylic acid derivative and method for making same |
| 06/10/2009 | CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/09/2009 | US7544812 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus |
| 06/09/2009 | US7544807 Ionic liquids |
| 06/09/2009 | US7544806 Piperidine-substituted indoles-or heteroderivatives thereof |
| 06/09/2009 | US7544803 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders |
| 06/09/2009 | US7544799 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 06/09/2009 | US7544709 Derivatives of andrimide and moiramide B having antibacterial properties |
| 06/09/2009 | US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 06/09/2009 | US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/09/2009 | US7544690 MCH receptor antagonists |
| 06/09/2009 | US7544688 Hetereoaryl nitrile derivatives |
| 06/09/2009 | US7544687 (2S)-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-ethoxy]-phenyl}-2-(4-m-tolyl-piperazin-1-yl)-propionic acid; hyperglycemia, dyslipidemia, type II diabetes mellitus; (2S)-2-[4-(4-nitro-benzenesulfonyl)-piperazin-1-yl]-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid; |
| 06/09/2009 | US7544686 Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof |
| 06/09/2009 | US7544675 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 06/09/2009 | US7544312 Charge transport compositions and electronic devices made with such compositions |
| 06/09/2009 | US7544215 Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds |
| 06/09/2009 | CA2583764C Thrombopoietin activity modulating compounds and methods |
| 06/09/2009 | CA2424470C Treatment of gastrointestinal stromal tumors |
| 06/09/2009 | CA2401812C Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009070693A2 Modulators of ocular oxidative stress |
| 06/04/2009 | WO2009070645A1 Indoles, derivatives, and analogs thereof and uses thereof |
| 06/04/2009 | WO2009070116A1 A quinoline derivative acting as a p2x7-receptor antagonist |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069680A1 Medicinal composition for treating gastrointestinal stromal tumor (gist) and kit and method for estimating the prognosis of patient suffering from gastrointestinal stromal tumor |
| 06/04/2009 | WO2009068652A1 2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines as soluble guanylate cyclase activators |
| 06/04/2009 | WO2009068552A1 Piperazinyl-sulfonamide derivatives useful in the treatment of gpr38 receptor mediated diseases |
| 06/04/2009 | WO2009068512A1 2 -amino-pyrimidine derivatives as histamine h4 antagonists |
| 06/04/2009 | WO2009068468A2 Pyridine compounds |
| 06/04/2009 | WO2009068194A2 Halogen-substituted δ1 pyrrolines |
| 06/04/2009 | WO2009045992A3 C-met protein kinase inhibitors |
| 06/04/2009 | WO2009004427A3 Benzimidazole derivatives |